Dietary Inflammatory Index (DII)

2

Review clinical trials related to Dietary Inflammatory Index (DII). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Inflammation and Diabetes: Evaluating Antioxidant Levels

The goal of this observational, cross-sectional study is to evaluate the relationships between dietary total antioxidant capacity, systemic inflammatory response markers, and nutritional parameters in adult patients with Type 2 Diabetes (T2DM). Participants will be classified into controlled (HbA1c \< %7) and uncontrolled (HbA1c ≥ %7) diabetes groups based on their glycemic control. The main questions it aims to answer are: Does dietary antioxidant capacity affect systemic inflammation levels and metabolic parameters? Is there a relationship between nutritional risk status and inflammatory response in T2DM patients?

Participants needed: 180
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Istanbul Bilgi UniversityUpdated: Jul 29, 2026Locations: 1
Eligibility criteria

Adults aged 18 and older diagnosed with Type 2 Diabetes. [+2]

Missing required laboratory data in the last 1 month. [+7]

Status: Not yet recruiting

Dietary Inflammatory Potential in Young Pleople With Obesity

The increase in adipose tissue in the young population is one of the most important and worrying public health problems because it persists in adulthood, constituting a risk factor for chronic degenerative diseases with social, economic, and environmental effects. The etiology of obesity is multifactorial and is associated with a low-intensity chronic inflammation process. Therefore, side effects of the digestive, nervous, endocrine, and immunological levels are closely related. Thus, understanding the impact of dietary components on the immune response and the pathophysiological complications of obesity will strengthen information on nutritional patterns with lower inflammatory implications.

Participants needed: 170
Trial details
Age: 18-24Biological sex: AllType: ObservationalSponsor: Instituto Tecnológico y de Estudios Superiores de OccidenteUpdated: May 14, 2025
Eligibility criteria

Both sexes with no gender exclusion [+3]

Pregnancy or expected pregnancy within the next month [+12]